Explore
Premium
Sign Up
Log In
Expanding Indications for TAVR – What Should Be Next? - Michael Reardon
↳ This is a section part of Moment:
CRT 2017 : VALVE & STRUCTURAL - AORTIC - Transcatheter Aortic Valves
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$12.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Preview
Summary
Expanding Indications for TAVR – What Should Be Next? - Michael Reardon at CRT 2017.
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$12.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Target Audience
Learning Objectives
Other Components in this Moment
Overview
Patient Selection and TAVR vs. SAVR: Are We Ready for Low-Risk Patients? - Ron Waksman
What Does the Future Hold for Alternative Access? - Vinayak Bapat
Expanding Indications for TAVR – What Should Be Next? - Michael Reardon
Second Generation TAVR Devices for Bicuspid Disease - Didier Tchetche
TAVR: Valve Thrombosis and Leaflet Thickening – 2016 Update - Raj Makkar
TAVR Durability, Reality and Expectations: A Careful Relook at the Data - Danny Dvir
Loading Simple Education
